Cancer Research Institute, Inc.

CRI has been a huge supporter of our science. We are positioned to be able to change the world, and improve care for cancer patients. In addition, we are training the next generation of cancer biologists, chemical biologist, and molecular imagers! There is no doubt in my mind of the phenomenal impact of CRI on basic and translational science for the field of oncology.

As a physician-scientist I appreciate that CRI pushes the boundaries of cutting-edge research in tumor immunology and immunotherapy that may benefit patients in the short term. As an applicant to a grant mechanism, proposing a high-risk, high-reward idea, I was impressed not only by the investment CRI made in my group and research, but also the incredible professionalism and efficiency in the process. These are all the ingredients needed to make a major impact.

I am a stage IV metastatic colon cancer survivor, originally diagnosed over 10 years ago. It is thanks to the immunotherapy treatments resulting from research funded by CRI that I am not only alive but living life to the fullest with hope for the future. CRI is an incredible organization that not only gives substantial financial support for the medical research that will lead to many more survivors like me, but also has essential resources for patients, clinical trial navigators and an amazing community of ImmunoAdvocates, which I am grateful to be a part of, providing patient advocacy and spreading awareness. From research to treatment, from patient support and all the way through survivorship, CRI is ever present as a fundamental and integral part of the cancer community.

I am a Postdoctoral Fellow supported by the CRI Immuno-Informatics Fellowship, which has been instrumental in enabling my research on harnessing AI and machine learning to study how to program immune cells to fight cancer. CRI provides not only the crucial funding that allows me to bring interdisciplinary approaches to potential cancer immunotherapies but also invaluable connections to leaders in the field. The recent CRI-ENCI Immunotherapy Conference was an incredible experience, where I had the opportunity to present my work and engage with inspiring scientists from around the world. This fellowship truly empowers young researchers like me to translate innovative ideas into experimental progress, advancing the fight against cancer.

The Cancer Research Institute has been instrumental in shaping my career and research as a postdoc. CRI’s unwavering dedication to advancing immunotherapy for cancer is matched by its support for early-career scientists like myself, providing us not only with essential funding but also with invaluable mentorship and collaboration opportunities. Through CRI’s network, I’ve been able to connect with leading experts in immuno-oncology and gain insights into cutting-edge techniques that I’ve applied directly to my research on the tumor microenvironment in pancreatic cancer.

CRI has just funded my project which will allow us to investigate how immune cells participate in cancer. This work would not be possible without their generous support.

Merhaba Aygun hanim ve tum Ceri Ailesi,

Ben, Omruye Mauser,.

Turkiyede 1 yil once akciger ameliyati oldum.Simdi Amerikadayim.

Ameliyat sonrasi gerekli testlerimin yapilabilmesi ve hastaligimla ilgili direkt ilgili doktor bulma ,doktorun beni hastasi olarak kabul etmesi, hatta sigortamla ilgili problemlerimin cozumu ve daha iyi bir pozisyonda olmam konusunda ; Dr.Aygun Sahin hanim ve CERI vakfinin yardimi ve olagan ustu calismalari sayesinde,(corona virusun yarattigi olanaksizliklarida eklemem gerekir.)
Son derece hizli ve zamaninda hastaligimla ilgilenebiliyorum.
Kendimi guvenli ellere teslim etmis olmamin rahatligini yasiyorum.,Bana gerekli olan doktorlari bulma ve tedavi sekillerini bilmem ve arastirmam nerede ise imkansiz iken ,CERI vakfi sayesinde ,hem bilinclenip hemde sonuca vaktinde ulasiyorum.

IYIKI VARSINIZ......Cok ama cok tesekkur ederim. Isiginizin benim gibi hastalara yansitmanizin devamliligi dilegi ile.
Iyi ve basarili gunler dilerim.

Omruye Mauser

CRI has a mission to save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer.
As an ImmunoAdvocate via CRI I have been lucky enough to work with/along side them as they continue to advance the conversation and community of cancer battlers and survivors.

CRI has been the most important source outside of NIH itself for funding research in cancer immunology and specifically for supporting emerging leaders in the field through their postdoctoral fellowship training and during their explorations of high-risk, high-reward work in their early- to mid-career faculty positions. CRI's impact now extends to brokering collaborative work between multiple pharmaceutical companies and multiple academic groups. CRI deserves enormous credit for the emergence of immuno-oncology as one of the leading frontiers in contemporary biomedicine.

Thank you so much for the great support CRI has offered to all post-doctoral fellows. It is the support that advances the next generation scientists who will revolutionize cancer treatment.

CRI is a remarkable organization founded on the premise - long ignored by other cancer foundations - that the immune system is capable of combating cancer. Recent developments in cancer immunotherapy have proved, spectacularly, that this premise is correct. CRI funding has helped the careers of many brilliant young scientists and it has been a pleasure to be involved in the process of reading and evaluating some of their applications

By supporting some of the best young minds in the world to perform basic research on the immune system and cancer, CRI has long had and continues to have a huge positive impact on science and medicine. We never know whether the next great discovery, like immune checkpoint inhibitors, might come from. By funding young scientists in some of their most creative years to perform high risk-high reward research, CRI primes the engine of transformative discovery.

CRI has most adamantly believed in the power of our immune system in the "war on caner" for decades. CRI's generous support of cutting-edge tumor immunology and basic immunology research has transformed, and will continue to transform the landscape of cancer therapies .

CRI is an amazing cancer research foundation that really makes an impact on supporting cancer immunology research, which is the LEADING EDGE of cancer therapies right now. They invest in the next generation of scientists and the CRI postdoctoral fellows are some of the best in the world, working on some of the newest frontiers of immuno-oncology. I am a cancer immunologist at the Salk Institute and with CRI's support our lab has been able to develop entirely new ways of thinking about the connections between metabolic regulation of cancer and immunity as well as how cancers develop resistance to cancer therapies aimed at stimulating our immune system.

CRI almost single handedly kept the flame of cancer immunotherapy alive while the NCI, AACR and most other cancer charities/funders ignored it. It has been, and remains, an essential organization for research funding, education, outreach, and scientific advance.

I'm proud to have served as an advisor to CRI during the process of judging candidates for CRI post-doctoral fellowships. The panel of advisors are outstanding scientists from across the country who meet twice a year to review fellowship applications. These applications are from fabulous young scientists (usually recent Ph.D recipients) eager to receive training in basic, translational or clinical research. The CRI has supported post-doctoral fellows performing so much of the research leading to the current successes in turning the immune system against cancer. Having seen first-hand how well the fellowship selection process functions, I am also proud to make my own annual financial contribution to the CRI. It is such an outstanding organization.

Thanks to CRI, and the funding they provide for numerous clinical trials for immunotherapy, I am alive. The care and attention this organization provides to help researchers study immunotherapy in treating cancer means the clinicians who minister to patients have options in cancer care that are more effective than ever before.
I was fortunate to participate in a clinical trial using immunotherapy drug Keytruda to treat my stage 4 ampullary cancer. With the prognosis near certain death, the immunotherapy cured the cancer in months.
My experience in supporting CRI since my cure has been exemplary and I wholeheartedly support them in every way I can.

Cancer Research Institute has top-level senior scientists in cancer and immunology fields to steer funding towards researchers and projects that have high potential to make new breakthroughs in cancer immunotherapy. Thank you, CRI !

The Cancer Research Institute (CRI) is an amazing organization that provides me with an unparalleled platform to conduct my research in cancer immunotherapy. In addition, CRI has given me a great opportunity to reach out to and collaborate with other outstanding scientists in this field. Importantly, as an international postdoc, I am most grateful for CRI’s decision to support merit-based research for scientists with diverse backgrounds or nationalities. Thank you CRI!

The Cancer Research Institute is an amazing organization that provides critical support to both basic and translational research aimed at harnessing the immune system to fight cancer. Funding from the CRI has been integral to my postdoctoral research and has further fueled my passion for cancer immunotherapy. For this, I am extremely grateful and would like to thank the CRI and its many donors for their continued dedication and support to young immunologists and the field of cancer research.

Curing cancer is my dream. I have had the great fortune to receive support from the Cancer Research Institute (CRI) and work as a postdoctoral researcher at Massachusetts General Hospital and Harvard Medical School. The generous support from CRI provides me an extraordinary opportunity to explore how the immune system fights tumors and develop novel strategies to overcome resistance to current therapies, and most importantly, bring hope to cancer patients! Thank you, Cancer Research Institute!

I am an early career scientist focusing on tumor immunity. CRI provides essential support for my research. In addition to financial support, CRI provides numerous opportunities for training and collaboration. I am thrilled to be a part of the CRI community.

The Cancer Research Institute has been funding postdoctoral fellows in my laboratory for a number of years now and I am very grateful for their contribution to my research. The peer review process for their fellowship and grant programs is very rigorous and their support is amazing. The support CRI provides to Fellows to collaborate and network in the broad field of immunological and cancer research is crucial for their career development.
The vision CRI had when starting to promote the involvement of the immune system in cancer research is truly remarkable and has led to several breakthroughs in the way we treat this devastating disease.

I'm a young scientist who is eager to help fighting cancers by doing basic research. With a three-year postdoctoral fellowship from Cancer Research Institute, I’m hoping to dissect the complexity of signaling in the tumor environment and help improve therapeutics for all cancers. I really appreciate CRI's generous support in cultivating the future of cancer research, and its effort bringing the fruit of science to the patients.

As a CRI-sponsored post-doctoral fellow, CRI is playing critical roles in my scientific career. CRI does not only provide me with a stipend, but also exposes me to great ideas from other fellows and senior scientists during the annual conference. Cancer is still a devastating disease, but the CRI community is trying best to conquer cancer.

Thanks to the Cancer Research Institute, I've been awarded with essential funding to research essential aspects of cancer biology. I'd like to highlight, that they fund translational research as well as basic research. This demonstrates that their criteria to select grantees are based on expert scientific views. Thank you for many discoveries to come!

I am an Australian cancer immunology research scientist and The Cancer Research Institute has funded my research on and off for more than a decade. Their funding is peer reviewed and well considered across many programs, including those funding early career scientists. They were responsible for the annual meetings in this area of research since 2000 and I met virtually all of my most important collaborators from all over the world in the field at these meetings. Their web site has been one of the best public educational tools in the field. Their leadership has been brilliant and their staff loyal, friendly and helpful over all of those years. In summary they have greatly enriched my career and provided the world great service.

CRI is a big support for my postdoctoral research. I am studying the gene regulatory network of T cell development, which is essential to understand cancer immunobiology. Without the funding from the CRI, I would not be able to fully focus on the factors that I am working now. I am so grateful for CRI's work to support basic science and translational researches!

CRI was the FIRST charity to dedicate their mission to advancing engaging the immune system to fight cancer. They have supported hundreds of young scientists and physicians to bring them into this field that has transformed cancer therapy. An absolutely amazing organization that is totally dedicated towards curing cancer using your own immune system.

CRI funding has been transformative for the field of cancer immunotherapy and is driving major innovation in the field. Our lab's funding from CRI is enabling us to take big risks and push forward in new directions that we hope will continue to expand the reach of immunotherapies to treat cancers that are not yet responding to therapies. I am profoundly grateful for CRI's tireless work to promote fundamental inquiry and clinical translation of immunotherapy.

The Cancer Research Institute (CRI) is an amazing nonprofit offering a plethora of Immunotherapy resources to gain knowledge, stay updated, seek Clinical Trial offerings and to connect with fellow cancer patients/caregivers/medical personnel. CRI funds promising Immunotherapy research that is changing the cancer treatment landscape and is saving and changing lives. Knowledge is power and as a Patient Advocate, I have been fortunate to participate as a Patient Speaker and attend several of their annual Immunotherapy Patient Summits. I am always in awe of the Researchers and Doctors asked to share their work at the Patient Summits. Knowledge, Hope, Inspiration and Support is transpired to all those that attend the annual Patient Summits. I applaud CRI for all that they do and for funding Immunotherapy Research so that I could still be here alive today!

Cancer Research Institute is the oldest non profit organization focusing on immunotherapy and funds the best scientists in the field . By sharing my story and experience with immunotherapy CRI has given me a chance to give back and share hope with other patients. Their Immunotherapy Patient Summits are free educational events that give patients access to experts in the field and advocates who have been treated with immunotherapy. Knowledge is empowering when faced with a cancer diagnosis. Clinical trial navigators are available to assist patients in discovering trials that may benefit them. Cancer Research Institute is a trusted source of information for patients who want to learn more about immunotherapy and it’s potential.

CRI sponsored my lab's research looking into how tumor hypoxia (low oxygen concentration) created a barrier that helped make prostate and pancreatic cancer almost totally immune to the FDA-approved immunotherapy antibodies. This critical support and lead-of-faith from CRI in believing in our work when others did not allowed us to 1) generated critical pre-clinical data to secure a larger grant, 2) published a high-impact paper describing how ablation of hypoxia sensitized prostate cancer to immunotherapy, and 3) eventually launch a clinical trial in which prostate and pancreatic cancer patients are now benefiting from this approach. Thank you CRI for helping us all engage the immune system to wipe out cancer!

The ambition and dedication of CRI in addressing the most urgent questions in the field of cancer immunology and immunotherapy have made a difference to the world. I am very grateful to be supported by CRI to pursue an exciting career in the field and be part of the excellent community.

I am an early-career scientist with a strong interest in understanding how tumors evade the immune system during cancer progression and metastasis. The Cancer Research Institute has been on the forefront of immunotherapy research, and decades of work have paid off with exciting results with new immunotherapy treatments. However, not all tumors respond to immunotherapy, and metastasis remains a leading cause of cancer death. The Cancer Research Institute has directly supported my work on understanding how pancreatic cancer regulates the immune system to allow for tumor growth and the spread of the disease. This work has the potential to provide key insights into strategies for activating an anti-tumor immune response. Thank you, Cancer Research Institute!

I am a postdoctoral researcher fortunate to have been supported by the CRI Irvington Postdoctoral Fellowship. It is truly commendable that CRI recognizes the value of basic immunological research, and that it is committed to supporting young researchers like me who are pursuing these questions.

I hope those comprising CRI are interested in 2lbs of stevia curing my uncle's 6 in transition phase to cancer breast tumors. He'd just lost his prostate to cancer, and thought his life was over. Adding the facts 62lbs of flab melted off with no hanging/flabby skin, and type 2 diabetes no longer registering makes this seem like a fairy tale, but those results did happen.

Stevia is very high in alkalinity, I've read that a high alkaline diet= a difficult environment for cancer and other diseases from living inside those bodies, and am hoping that someone at CRI is interested in investigating these valid claims.

I am a postdoctoral scientist at Harvard Medical School, studying how the immune system reacts to insults by infections and cancer. CRI is funding my research since the beginning of this year and I am very grateful for this. It is a great honor for me to get awarded a CRI fellowship, which is well-known as a very prestigious fellowship. CRI recognizes the necessity to fund basic research in order to advance the clinic.

As a CRI-funded postdoctoral fellow, I could speak all day about the tireless efforts of the CRI to fund basic and translational research and bring immunotherapy to the clinic. The most significant thing for me is that the CRI awards grants based on scientific merit, regardless of nationality or location of research. Which means that they funded me (a non-American citizen/non-permanent resident) to do cancer research in France. I am greatly indebted to the CRI and its donors for believing in the value of my research, and will continue to work my tail off throughout my career to make their early investment in me a worthwhile one. Thank you CRI!

CRI has played a significant role in my career as a young scientist by funding three years of my postdoctoral research at Caltech. In addition to direct support, I have greatly enjoyed the opportunities CRI has provided to network and collaborate with scientists involved in a very broad range of immunological and cancer research. They do a great job of bringing everyone - from basic researchers to clinicians - to the same table to address really important problems.

The CRI has played an integral part in my development as a scientist and cancer researcher. The organization is perceptive enough to still fund high risk though highly rewarding research. I was lucky enough to receive a postdoctoral research fellowship from them this year to study how intestinal bacteria affect the progression of colorectal cancer using advanced chemical techniques. It is an honor to be included in the outstanding research that is funded and supported by the CRI. A true gem in the cancer research field!

The CRI is supporting my project this year, in which we are trying to develop new strategies for cancer immunotherapy. It's such an honour for me, especially knowing that Lieping, one of the major contributors to the newly breakthrough in immunotherapy, was also supported by the CRI in his early years. The work CRI has supported proves that they have done a really great job in pushing the researches in cancer forward during the past decades.

The CRI began funding my post-doctoral work this year. This has allowed me to work on understanding the immune response to metastasis, however, through the events the CRI runs they have also allowed me to network with other young cancer immunologists producing numerous contacts and potential collaborations which will help move this work forward.

More than 15 years ago I had been very lucky to receive a research fellowship from CRI. That support turned out to be very important in allowing me to finish a study that became my modest contribution to the knowledge of differences in gene regulation between mouse and human immune cells. Later on, I became involved in an educational program in tumor immunology in Moscow, Russia. Due to generous CRI support, we were able to invite very best scientists to come to Moscow specifically for teaching. Many students of that program are now successful young researchers advancing the flourishing field of tumor immunology. Over the years I have attended several CRI symposia and had the privilege of personally meeting a number of CRI administrators and employees including its late scientific director Dr.Lloyd Old. I think Dr.Old was an absolutely great scientist and visionary, and all the members of his team are highly professional bright people dedicated to fighting cancer using immunity. CRI is continuing to do a magnificent job in helping cancer immunology research.

The CRI has supported me as a budding researcher in the field of cancer immunotherapy over the past two years. Beyond funding my research in the lab, the CRI has coordinated my interactions with scientists and physicians to inspire new cutting-edge ideas. The CRI also helps to eliminate the disconnect between scientists and patients by setting up meetings with immunotherapy recipients, allowing us to truly see and feel the effect we are having on so many lives. The payoff for their efforts has been fully realized in the last decade, with cancer immunotherapy (their primary focus) being recognized as the Science magazine breakthrough of the year in 2013.

The CRI has been at the forefront of cancer immunology research for decades. The growing success of cancer therapies aimed at the immune system is in no small part due to the efforts of the CRI. As a fellow with CRI funding, I am very grateful for their support, which is allowing me to hone my immunology training for a career in cancer immunology. This organization is not simply a distributor of cash, however. I have been struck by the enthusiasm and optimism of the CRI staff (scientific or otherwise), their desire to engage the public to increase cancer awareness, and their ability to foster a highly collegial environment that is unsurpassed by any other nonprofit I've interacted with. The CRI is doing a great job, and I'm proud to be one of their fellows!

CRI has consistently funded the best people in cancer research to do ground breaking translational research in cancer, and has also provided a cutting edge forum for many years for discussion of the now clearly useful field of cancer immunology.

The research CRI is currently founding has the potential to save many lives and to greatly increase the knowledge of mechanisms underlying the interplay between tumor cells and the immune system. They are definitively doing an amazing job.

I have been supported by CRI postdoctoral fellowship since 2013, just like hundreds of other researchers CRI supported for decades. Thanks to their efforts, promising immune therapies and drugs have been greatly developed in cancer treatment. Although my research is not directly on clinical, the annual symposium provides great opportunity for me to learn about the latest progress on cancer therapies. Sharing researches with clinicians and other CRI fellows inspire novel ideas and facilitate collaborations.

I am a post-doctoral scientist at UCSF who's research is supported by CRI, for which I am very grateful. I have been extremely impressed with the breadth of research funded by CRI and I firmly believe that CRI does an outstanding job of advancing the treatment of human diseases though advances in basic biology.

Great institute to really support research that makes a difference in cancer diagnosis and treatment. I appreciate the research funds given by CRI to allow us to tackle the immune system for cancer treatment.

I am supported by CRI as a postdoctoral researcher at the University of California, San Francisco. I was ecstatic to start work that will help us learn more about tumor-related inflammation and the damage it can cause. I recently had the opportunity to attend a CRI meeting in New York and was astounded by the quality of work that CRI supports across the country and the passion with which these researchers tackle problems central to cancer treatment. I would encourage you to support this fantastic organization. Thanks!

As a cancer researcher, I highly endorse the fantastic work done by the Cancer Research Institute (CRI). The CRI is the premier non-profit organization in the realm of cancer immunotherapy, which can lead to durable responses not seen using other therapeutic approaches. (For this reason, cancer immunotherapy was recently highlighted as the Breakthrough of the Year for 2013 by the prestigious journal Science.) In addition to organizing clinical trial information for patients and hosting a fantastic biennial conference for scientists, the CRI funds exceptional trainees and cutting-edge research in order to work towards a cure for cancer. Independent analysis by Charity Navigator reveals that the CRI has earned the top four-star rating, scoring 94% on financial and a perfect 100% on accountability and transparency (http://www.charitynavigator.org/index.cfm?bay=search.summary&orgid=3417#.VEAryktUBD4).

I am a graduate student at the University of California - Berkeley. My doctoral work focuses on the role of the immune system in fighting cancer. In Sept 2013, I was awarded a fellowship from the CRI to fund my research. This fellowship has allowed me the academic and financial freedom to pursue research directly related to human disease.I cannot speak highly enough of the CRI's work. The CRI has supported hundreds of scientists in the fight against cancer through direct research funding. In addition, the CRI organizes various annual symposia to allow scientists and clinicians to share research and discuss collaborative projects. Through these activities, the CRI has made a wonderful contribution to the field of cancer research, and it's work has had a direct impact on the development of novel, promising therapies for the treatment of cancer.

Funding from the CRI allows me to conduct a clinical trial in late stage cervical cancer patients that otherwise have little hope for a cure.

I am a post-doc at The Rockefeller University, and receives CRI post-doc fellowship. The funding from CRI greatly helps my ongoing research in the field of cancer and immunology. Myself also benefits greatly from attending the events organized by CRI, such as the annual international cancer immunotherapy meeting. These events greatly broaden my scientific horizon and provide the changes to collaborate with other scientists in the field to do great science together!

The Cancer Research Institute (CRI) has funded my research as a postdoctoral fellow at the University of Washington since 2013.

The CRI has supported my postdoctoral research since 2012 through one of their competitive fellowship awards. Thanks to this amazing support we have developed new therapeutic strategies to re-direct the immune system against aggressive malignancies such as ovarian cancer. Transforming devastating cancers into curable diseases will only be possible through immunotherapy, and the CRI is substantially leading this vital task.

I was awarded a CRI fellowship to conduct my research at the University of Pennsylvania. This incredibly generous support for basic research that has really laid the foundation for my postdoctoral career, and has allowed me to focus on developing as a scientist. This funding will allow our research team to further develop our basic understanding of how immunotherapy works in cancer, which will hopefully continue to shape the way we approach this therapy in patients.

They give me very good support on my research and are together with me all the time. With the help from them, I made good progress with my research, which provides further understanding of B cell lymphomas.

I was awarded CRI fellowship to conduct my research at the University of Chicago. This helped us to identify pathways critical to leukemias and lymphomas.

CRI's generous and continued support of our research in cancer immunology and cancer immunotherapy helped us to establish a sustainable clinical research and teaching/training program in the field. New students and young researchers were introduced to the field as MD/PhD students and young faculty. CRI's CVC helped to establish a Clinical Trials Center at the University of Zurich. Ultra-lean management and great communication skills with an outstanding scientific faculty advising characterize CRI's success as a non-profit organization focused on Cancer Immunology and Cancer Immunotherapy.

I was awarded a CRI postdoc fellowship a few years ago, which turns me from a scientific worker to a scientist. The critical difference between these two is that the later endowed with a great passion and motivation for research which grew in me during this postdoctoral training phases. Without the support from CRI, this transformation will not likely happen. Thank CRI for training young people in the cancer research field, and I believe our research will eventually provide great benefits for cancer patients.

During my postdoctoral studies at the section of Immunobiology at Yale Medical School I have been a CRI fellow studying the transcriptional regulation of cytokine genes driving the differentiation processes of T helper cells. During that period, and having peace of mind because CRI was funding my research, we were able to advance our knowledge about gene regulation and show that the three dimensional structure of the genome affects the expression profile of a locus. More importantly others have shown that proximity of gene loci in the 3D nucleus increase the probability for a translocation event usually found in leukemia and tumors.
The funding I have received during my postdoctoral studies was of fundamental importance and helped me get an Assistant Professorship. And again my good angel CRI was there to support my research with an Investigator award. This gave a kickstart to my career and my first steps as an independent investigator. I am really proud being part of this team of people who are dedicated and hard working with the ultimate goal of conquering cancer.

I was the recipient of a CRI postdoctoral fellowship award that funded my research in the function of the innate immune system during aging at MIT. Because of the generous support of CRI, I was able to make important discoveries that I anticipate will help to form the foundation of further study in age-dependent dynamics of signaling pathways that regulate the immune response later in life. Throughout my years as a CRI fellow, I have found the staff at CRI to be professional, supportive, and truly dedicated to the cause of advancing scientific knowledge toward the goal of eliminating cancer. My heartfelt thanks goes to CRI, and I would strongly recommend CRI as a benefactor of those seeking to support biomedical research.

The Cancer Research Institute by wisely selecting and generously supporting investigators and projects on cancer research has immensely contributed to advance our understanding of malignancies, thus paving the way for novel therapies. With the support of the CRI we have developed new MHC-peptide based reagents that allow improved detection and isolation of antigen-specific CD8+ and CD8+ T lymphocytes. We endeavour after final optimization to make these reagents generally available, thus contributing to better monitor and understand cancer specific T cell immunity.

Twenty five years ago I received a posdoctoral fellowship from the CRI. This allowed me to get an unvaluable training in the field of cancer immunology that was the start of my scientific career. CRI did not mind the fact that I was a young physician just arrived in the US, and generously funded my research. CRI is the perfect example of a phylantropic organization in the frontier of new knowledge and humankind. I am now a top administrator of one of the largests European Universities and I remain grateful to CRI for their support.

As a former recipient of Cancer Research Institute postdoc fellowship, I am very grateful to CRI for the generous support to allow me to carry out frontier research work in chemical biology at Harvard University. It was an eye opening experience that not only broadened my understanding at the interface of chemistry and biology, but also gave me an inspiration to choose my own research topic related to cancer and immunology. In my independent academic work, I have benefited tremendously from that postdoctoral experience and I am glad I have made the right decision to develop new anticancer drugs.

In 2008, the Cancer Research Institute was the only agency that was
willing to fund a risky project whose objective it is to understand
why the immune system fails in the elderly. Since then, this study has
yielded exciting results on how aging of stem cells influences immune
function and we are currently preparing two manuscripts on our work.
We have recently procured a grant by the National Institute on Aging,
totaling $658,000, to follow up on these results. Obviously, we would
not have been able to undertake this project without the visionary
support of the Cancer Research Institute.

I was a recipient of funding from the CRI to conduct my postdoctoral research and I am a yearly donor to this institute. I am very positive about the CRI and their mission because they get results. They understand the process of discovery and innovation well enough to invest in basic research of the immune system because the findings that come from such basic studies are the building blocks of translational research. And, they have the vision to support efforts to take key basic findings from the bench to the bedside. A key case in point is the development of the immunotherapeutic drug Ipilimumab, which the CRI helped advance, as a treatment for melanoma.

I and my extended group have been the recipients of a ”matching grant”, awarded jointly by the Cancer Research Institute and the Concern Foundation, Los Angeles, over several years. This grant was used to support the work of 10-15 fellows each year, working in the areas of cancer cell genetics, tumor virology and tumor immunology. This generous grant has given us an unparalleled opportunity to pursue the research with a dynamic group of research fellows, postdoctorals and guest investigators. With the help of this grant we could keep talented young researchers who would have been otherwise forced into industry or other applied work.

The Cancer Research Institute has my greater admiration for the highly efficient, non-bureaucratic, talent- and problem-oriented support that characterizes their fellowship program.

I was supported by CRI for my Postdoctoral fellowship, and it provided me a wonderful period to study and work in one of the best lab of cancer immunology in the world. The society of CRI also have been providing me a opportunity to communicate with great scientists. Annual meeting in NY always stimulates me a lot when I attend.

My family has been involved with donations for CRI for about 35 years. One of the major draws was Dr. Lloyd Old. He has helped guide us to maximize the use of our contribution. Our experience has been nothing short of exemplary.
The staff and scientists there have spent a great deal of time interacting with us to make sure that we comprehended the impact of the research to be done. Most recently, I was able to attend their immunological conference. This gave me first hand experience to the research. It was interesting and fun to engage with the scientists. They were very helpful to explain concepts I did not quite grasp.

I very much liked this type of interaction and hope that I may continue to participate in this way. I feel it allows me to argue more effectively the case to continue giving to CRI.

The Cancer Research Institute has been generous in allowing me to pursue post-graduate studies in the area of lung cancer. Thankyou for allowing me to pursue an exciting, at times tough and challenging, yet tremendously rewarding path into the medical research future. We are now studying lung cancer patients with the hope of understanding how their lung immune microenvironment may protect against or worsen their disease.

I was supported by a postdoctoral fellowship by the Cancer Research institute. The funding allowed me to pursue research studying basic T cell immunology. Their support has been invaluable to helping my career progression towards making fundamental discoveries in immunology. Now I am an assistant professor and I have again applied for funding from the CRI, as the CRI supports scientists at multiple stages in our careers. Continuing support from the CRI will allow me to progress in my studies regarding the role of immunology in cancer.

For the past 3 years, the Cancer Research Institute has supported a postdoctoral fellow in my laboratory. With federal funding for biomedical research in decline, much important research related to cancer (and literally any other human disease) could not be done without the dedicated and unwavering support from private non-profit organizations like the Cancer Research Institute. The high standards during the initial peer review of projects, the continued support and the annual meeting all provide outstanding opportunities for young investigators to learn and to network with other professionals in their fields.

I am funded by CRI as a postdoctoral fellow to do fundamental research in immunology. I am extremely impressed by how dedicated CRI is to the goal of using a greater understanding of the immune system in order to combat cancer. As can be seen from the very important recent advances in therapeutics that have come from this approach, CRI's investment in this field is profoundly impacting cancer research and treatment.

The Cancer Research Institute plays a very important role to support the work of scientists who have original ideas of cancer immunotherapy, which are promising, but not yet proven enough for obtaining financial support from commercial groups. In our laboratory we had the idea of localizing on tumor cells, with specific monoclonal antibodies, molecules, such as Major Histocompatibility Complexe (MHC), loaded with viral peptides, which can activate the T lymphocytes to attack the target tumor cells. Thank to a 3 years support provided by CRI, a senior post doc in our group, Dr Alena Donda, we were able to make the first demonstration of this therapeutic strategy in experimental animals (Donda et al. Cancer Immunity 2003). Furthermore, Dr Donda demonstrated that an MHC like molecules, called CD1d, loaded with a glycolipid ligand, called alphaGalCer, also targeted to the tumor cells by monoclonal antibodies, was capable to specifically inhibit tumor growth in vivo (Donda et al. J. Clin. Invest. 2008) and to give a sustained activation of the Natural Killer Cells known to be important in the innate immunity. Later this project was sponsored by industry, and may become a clinically useful form of cancer therapy; but the role of CRI in the initiation of this project was essential.

the Cancer Research Institute not only funded my postdoctoral research in tumor immunology but inserted me into the perfect environment to start building my research career. Through their PhD, postdoctoral and new investigator awards programs plus their anual meetings, the CRI puts together an impressive group of scientists all with different expertises and ideas but at the same time all with the same general goal: to defeat cancer.

The caliber of the scientists involved in CRI is simply outstanding, and the fact that many times a year they are all put together in the same room to discuss failures and successes in our fight against cancer has definitively yielded promising results. This is the perfect environment to be inserted as a young investigator and I am really grateful to have had the opportunity to be part of this group of scientist. Most importantly, the network of scientists generated under CRI's umbrella is a permanent one, as investigators continue to interact and collaborate in cancer related projects for much longer than their CRI sponsored funding.

CRI is much more than a charity or funding agency, is truly an incubator for fantastic science, research and development.

The funding provided by CRI allowed me to support a wonderfully talented postdoctoral fellow from Africa to embark on an almost entirely unexplored area of research relevant to human infectious diseases, autoimmune disease and cancer. These studies open up an important new area of research specifically related to human immunology. Because of hard work and enthusiasm this fellow has made much additional progress on investigations related to the understanding of a spectrum of virus-associated cancers that occur word-wide, to autoimmune disease and tumor immunology; moreover this young scientist is now well on the way to an independent career. Without the constant support of CRI this would not have been possible.

I am an Immunology researcher and have received funding from the Cancer Research Institute for my laboratory. As a new investigator, the CRI funding allowed me to get my research started quickly and allowed me to get results allowing me to successfully compete for NIH funding for my research focused on immunology, inflammation and autoimmune disease.

I received a grant from the CRI that was instrumental in allowing me to get my laboratory started at Washington University. CRI is a wonderful organization and I will always be grateful for their support at an early and critical stage of my career. I have now been running my lab for 13 years and we focus on how immune cells can become transformed leading to leukemia and lymphoma.

I was a recipient of 3 year postdoctoral fellowship from CRI. I think CRI is playing a crucial role in supporting young scientists to develop their career. It role is very important for our future of science, particularly when public funding is affected by economic crisis and politics.

CRI continues to play a critical role in the development of immunologic therapy for cancer.

I received three years fellowship from CRI for my research at the university of Chicago. This fellowship helped us to start a very competitive project . CRI grants help many labs to fund important research works especially when other funding sources are affected due to economic crisis. CRI is doing a great job of providing stable fundings . This allows us to focus on our research. I appreciate CRI's commitment towards science. I am very proud of being a part of CRI community.

I received a 3 year postdoctoral fellowship from the CRI, which was much appreciated. In addition to supporting high-quality science, the CRI brings its members together for an annual conference in New York City. This small, tightly knit meeting is one of the best I have ever attended. The CRI, as a whole, really believes in its mission of using basic science to fight cancer, and you can tell from the passion and the intellect of the people it brings together.

When I began my career in cancer research in 1989, CRI was the only organization that believed in supporting junior researchers as the future of cancer immunotherapy. I had just had my NIH grant turned down and CRI gave me an investigators grant that allowed me to launch my career. They then funded a number of postdoctoral fellows, who are now themselves independent cancer immunology leaders at institutions all over the world. Without CRI, I would not be doing this today. Starting in 2010, cancer immunotherapy has emerged as the "new" breakthrough approach to cancer therapy but this is actually the fruit of decades of labor and CRI has been steadfastly behind that research from the beginning.

I was a recipient of a CRI postdoctoral fellowship at the start of my independent scientific career to study very basic aspects of the immune system. I have always admired the wisdom and courage of the CRI to fund at the same time translational and very basic research in immunology. Furthermore, the quality of the scientific board and the technical staff is, in my opinion, outstanding, assuring that the funds are applied to truly worthy clinical and research programs in a very efficient manner.

The Cancer Research Institute (CRI) supports clinical research in a very productive manner. We received specific support for clinical research and development, which was key to the success of our projects. Investigator-initiated clinical studies are very difficult to finance, yet they represent a central element in modern medical centers. It is very important to move clinical research up the value scale, and the CRI plays a crucial role in this process. State-of-the-art academic studies are increasingly needed to promote bio-medical excellence at University Centers, in partnership with patients and their organizations, and with private enterprises.

As a past recipient of a CRI fellowship, I want to express my gratitude to a high profile Institution who helped move from the postdoctoral stage to my first group leader position - fast, unbureaucratic, efficient.

I applaud the Cancer Research Institute's support of young scientists and of research that is somewhat risky, but with potentially great rewards. This forward thinking helps to develop a new generation of scientists that are creative -- which allows for many more possibilities to be realized.

The CRI supports great researchers doing great research and helps to develop the next generation of health science research.

Two years ago, we came up with a hypothesis relating to how immunotolerance is induced and maintained upon tumor development. With the help of financial support from the CRI, we have been able to throw more light on this pathway and our findings have the potential to translate into the development of novel immunotherapy approaches for the treatment of cancer. Thank you CRI

As a recipient of funding from the Cancer Research Institute, I give it high marks for having the courage to fund the risky innovative science that NIH doesn't prioritize. Discoveries made by Cancer Research Institute scientists have made direct impacts on cancer therapy and is highly respected in the field.

The Cancer Research Institute represents a focused lean organization that is committed to seeing the important work done. They impact people's lives by helping to develop and deliver information, therapies and hope to patients with cancer. Their fund raising and success is largely a function of a very committed and dedicated staff that works in concert and has reduced the typical bureaucracy to a minimum. They provide promise of cures not in the far off distant future but more in the lifetimes of the patients that are dependent upon progress in the area of cancer treatments. In the past two years the financial crisis has made their work much more difficult but they have risen to the challenge.

I was fortunate to receive a CRI Career Award when I was just starting my lab at the University of Washington. This funding provided me the latitude to pursue ideas that were too risky to compete for NIH funding. This permitted me to develop a line of investigation that continues to prove fruitful and important.

I received a CRI postdoctoral award ~ 8 years ago which has ultimately helped me and the lab I was working in to make a major discovery in lymphocyte biology. It has also allowed me to become an independent investigator by sustaining my high-risk/high-reward project as a project. This paid off and it is critical that organizations like the CRI support basic immunology research, especially at a time when federal funding is limited and often not available for novel, unproven approaches. Of all organization that fund research in the field of cancer and lymphoma research, the CRI stands out because of its willingness to fund basic immunology research, its exceptional scientific advisory board and its vision to fund promising talent and unconventional approaches.

The Cancer Research Institute has been the fundamental body that has globally underpinned the whole discipline of cancer immunology. In Australia we have benefited from their graduate teaching program. It has funded a whole generation of Australia's next research leaders in cancer immunology.

My association with CRI began about five years ago, when the first of three postdoctoral fellows supported by CRI began work in my lab. I have also attended a number of CRI sponsored scientific meetings. This made a great difference to my work and to overall progress in the field.

Only if our scientists can understand how the basic mechanisms of our immune system and the cell work, can we ever hope to find a cure for this disease.
The Cancer Research Institute is a non-profit organization, that has devoted itself to find a cure for cancer.
They support basic research to elucidate the mechanisms involved in cancerogenesis as well as research that is aimed at finding out how our immune system and the processes in the cell work.

As a recipient of a CRI Investigator Research Award and a scientist working in South America, I have to say that receiving a grant from the CRI was the best experience at the begining of my scientific career in Tumor Immunology. The dedicated team of CRI staff and advisors devote all their experience and efforts at the interface of Fundamental Immunology and Oncology to find a cure for Cancer. Their advisory board composed of the Best Scientist in the Field, members of the Academy of Science and Nobel Prizes, select, without any bias or country discrimination, good scientific projects. Without any doubt, receiving a grant from the Cancer Research Institute fostered my scientific career and was one of the best experiences I had in my carreer. As you may imagine, trying to do good science in South America is difficult because of limited funding. Therefore, funding from the CRI was essential for me also to help me stay in my country without the needs of travelling to USA or Europe!

As a recipient of CRI's predoctoral fellowship, I had the fortunate experience to attend the annual scientific symposium sponsored by CRI which brings exceptional basic scientists in the fields of immunology and cancer biology together with oncologists tasked to implement novel immunotherapies. This conferences highlight CRI's great vision of sponsoring research at a fundamental level as well as supporting translational research.

Cancer research Institute was important to help my research during my post-doctoral work at Stanford University. The grant writing and review process was very competitive and rigorous. Proposals selected for grants shows the commitment CRI has for cancer research. I hope that CRI keeps raising the awareness for how important conducting research in this field is and how important it is for donors as well as federal agencies to fund cancer research. As a result of discoveries coming out of funding from non-profits, such as CRI, countless lives have been saved from this insidious disease.

Several postdoctoral fellows in my lab have received stipends from the CRI. This support has enabled us to take risks on projects that would never have been funded through traditional government sources. Consequently, we have been able to make unique advances in understanding the basic signaling mechanisms that control cells of the immune system, and how those go awry in cancer. The understanding by CRI of the importance of basic research in laying the groundwork for discovery of new therapeutics is remarkable, and deeply appreciated by the scientific and medical communities.

I have had the opportunity to witness first-hand the wonderful work that the Cancer Research Institute does from several angles. Firstly, I have had the opportunity to attend a couple of the symposia that the CRI has sponsored. I have found these symposia to be extremely informative and cutting edge. They have provided an opportunity for researchers from around the world to gather and share their ideas and experiences. I have also been the recipient of intellectual and financial support for my vaccine trial. This is one of the first immunotherapy trials specifically for children with the brain tumors in the United States. This trial was possible because of support from the Cancer Research Institute.

CRI is top notch and is making a valuable contribution to the fight against cancer.

I'm a recipient of a CRI investigator award. The funds came right during a time were federal research spending was flat and I was able to use those dollars to get my research project up and running. My lab has since been very productive and I'm grateful that CRI was there initially to jump start my career. I hope that some day I can repay the favor by making a groundbreaking discovery aimed at the treatment or prevention of cancer. One little step at a time.

CRI is at the forefront of supporting highly innovative and promising research that will have huge impact in cancer therapy. As a post-doc fellow funded by CRI, they have funded my research on a basic science field that would be considered risky as far as cancer relevance during that time. Yet, it turned out that research area is now one of the main focus for development of cancer therapy. They then funded me again as an Asst. Prof. and am immensely grateful for their support. Because of CRI funding, my lab has been able to obtain all these exciting findings that we hope will lead to new modes of therapy.

CRI has pioneered some of the most groundbreaking research in cancer and spearheaded the field of cancer immunology. The development of vaccines and potential drug therapies that are now the best in the world was initiated by CRI. Indeed, today the involvement of the immune system in cancer is best understood thanks to the efforts of CRI, which in turn has led to some of the best available cancer therapeutics.
CRI has also been extremely supportive of patient care and of patient outreach.

My experience of CRI as a beneficiary of their funding program has shown me how dedicated they are to find novel and effective cures for cancer. One of the few charities that I know of that understand the relevance of basic research in order to further cancer therapy. Moreover conferences and fundraisers sponsored by them go a long way in helping to translate cutting edge science into therapy.

CRI is well organized and understands the areas of cancer knowledge that must be improved to increase the effectiveness cancer immunotherapy. CRI funds top laboratories and scholars and brings disparate research together to facilitate synergy.

I was a recipient of a grant through the Cancer Research Institute Irvington post-doctoral fellowship program. This grant helped fund my research and career development that was critical to establish my own independent lab. Based on the work funded by the CRI and the long term projects it spawned we have published 40+ papers and used these findings to get further support from the National Cancer Institute. Our work will help leukemia and lymphoma patients and also applies to inflammatory diseases. Thanks to the CRI for being instrumental in getting it all started!

Cancer Research Institute has played an instrumental role in promoting science-based therapeutic discoveries. Their grant programs in particular has allowed many generations of scientists to develop novel ideas in the fight of cancers. It is a top-notch organization that I support whole-heartedly.

I give this organization my top rating because I am very familiar with the work they do. I was a participant in a cancer vaccine trial that was underwritten by the Cancer Research Institute. I know that this trial would not have happened without the research grant from CRI.

As a result of the clinical trial I participated in 7 years ago, I am still in remission from ovarian cancer today, and I am extremely grateful to CRI for their support of this small research study.

I have also had the opportunity to meet their staff and attend some fundraising events. They have a lean, well run organization with an admirably high percentage of funds going directly to grants for cancer immunotherapy research. I have also personally met several of the research scientists they support, and these are internationally known researchers with excellent credentials. They all say how important the financial support of CRI has been in making it possible to conduct their groundbreaking studies.

CRI has a fascinating website too, with some really great information on recent advances in cancer immunotherapy. Some of the current successes out there now such as Gardisil (cervical cancer vaccine) and Provenge (prostate cancer vaccine) came from researcher studies CRI helped to underwrite. A recently approved vaccine to prevent recurrence in melanoma is the latest CRI supported research effort on its way to the consumer market. So they are really accomplishing a lot.

This is a first-rate charity. It is one of the few I would actually contribute money to, because of their great track record in supporting cancer immunotherapy research, the many successes that have come out of the studies they help to fund, and the high standards they meet as a charitable organization.

In order to beat Cancer, it needs to be fully understood. Research carried out by people such as these is vital.